Sarah Fehr is a research-track resident at the University Hospital of Psychiatry Zürich. She is currently leading a randomized controlled trial investigating the use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of post-COVID-associated affective symptoms and associated immune system changes.